Search Results - "AlShehry, Nawal F"

The use of 5-azacytidine in pregnant patient with Acute Myeloid Leukemia (AML): a case report by Alrajhi, Abdullah M, Alhazzani, Sarah A, Alajaji, Nouf M, Alnajjar, Fouad H, Alshehry, Nawal F, Tailor, Imran K

“…The management of Acute Myeloid Leukemia (AML) during pregnancy remains challenging as both the maternal and fetal outcomes should be considered. Several…”
Get full text

Efficacy and Safety of Azacytidine in Combination With Fludarabine and High-Dose Cytarabine With G-CSF (FLAG) in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study by Motabi, Ibraheem H., Aoun, Shaima M. Al, Al-Ammari, Maged, Albtoosh, Belal M., Iqbal, Shahid, Altaf, Syed Y., Tailor, Imran K., Alnoamani, Mohammed S., AlGhamdi, Mubarak S., Zaidi, Syed ZA, AlShehry, Nawal F., Marei, Mohammed A., Alfayez, Mansour

Get full text

Outcome of myeloma patients with COVID-19 on active lenalidomide-based therapy: Does lenalidomide protect from severe COVID-19? by Tailor, Imran K., Alshehry, Nawal F., Zaidi, Syed Z., Marei, Mohammed A., Motabi, Ibraheem H., Alfayez, Mansour, Altaf, Syed Y.

Get full text

Prolonged Survival of a Patient with Chronic Myeloid Leukemia in Accelerated Phase with Recurrent Isolated Central Nervous System Blast Crisis by Bin Salman, Ahmed A, Zaidi, Abdul Rehman Zia, Altaf, Syed Yasir, AlShehry, Nawal F, Tailor, Imran K, Motabi, Ibraheem H, Zaidi, Syed Ziauddin A

“…BACKGROUND Chronic myeloid leukemia (CML) is usually a tri-phasic myeloproliferative neoplasm, characterized by the presence of the BCR-ABL1 fusion gene,…”
Get full text

COVID-19 and Palliative Care Services: Comparative Patterns of Inpatient, Outpatient, and Consultation Services in a Tertiary Care Center in Riyadh by AlShehery, Maied Z, Duraisamy, Balaji, Zaidi, Abdul Rehman Z, AlShehry, Nawal F, Zaidi, Fatima Z, Rababah, Ahmad A, Assiri, Abdulhakeem A, AlGhamdi, Mubarak S, Al Mutair, Abbas, Al-Omari, Awad

“…Introduction The coronavirus disease 2019 (COVID-19) outbreak caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) marked the third…”
Get full text

Lymphoproliferative Disorders in Patients with Chronic Myeloid Leukemia: A Single-Center Case Series by Alshehry, Nawal F, Al-Huneini, Mohammed, Lipton, Jeffrey H, Michelis, Fotios V

“…Lymphoproliferative disorders presenting simultaneously with or subsequent to the occurrence of chronic myeloid leukemia (CML) have rarely been reported…”
Get more information

Imatinib‐induced gastric antral vascular ectasia in a patient with chronic myeloid leukemia by Alshehry, Nawal F., Kortan, Paul, Lipton, Jeffrey H.

“…Key Clinical Message Gastric antral vascular ectasia (GAVE) has been reported very rarely in imatinib‐treated gastrointestinal stromal tumor (GIST) and…”
Get full text

Efficacy and Safety of AALL0232 Protocol in Adults with Acute Lymphoblastic Leukemia: Single Institution Experience by Alrajhi, Abdullah M., Alrouqi, Mashael, Howaidi, Jude, Alwadi, Mohammmad, Alshehri, Hassan, Tailor, Imran K, Alnoamani, Mohammed S, Alshehry, Nawal F, Motabi, Ibraheem H, Marei, Mohammed A, Alhumaid, Muhned

“…Background Over the past few decades, the outcomes for children with ALL have significantly improved with current regimens that yield a 5-year complete…”
Get full text

Excellent Outcomes of Patients of Middle Eastern Ethnic Origin with Autologous Haemopoietic Stem Cell Transplantation and COVID-19: Does a Dampened Immune System Protect Against Severe COVID-19? by Tailor, Imran K, Altaf, Syed Y, Alshehry, Nawal F, Alser, Alaa M, Marei, Mohammed, Alfayez, Mansour, Motabi, Ibraheem, Zaidi, Syed Ziauddin A

“…Introduction Outcomes of patients with hematological cancers and coronavirus disease 2019 (COVID-19) have been reported to be poor with high rates of…”
Get full text

Outcomes of Patients of Eastern Mediterranean Region with Lymphoma and COVID-19.Does Recent Chemo Immunotherapy Have a Role on Severity? by Tailor, Imran K, Alshehry, Nawal F, Sabir, Kamran, Zaidi, Abdul Rehman Z, Marei, Mohammed, Motabi, Ibraheem, Alfayez, Mansour, Zaidi, Syed Ziauddin A, Altaf, Syed Y

“…Introduction Outcomes of patients with hematological cancers and Corona Virus Disease-19 (COVID-19) have been dismal with high rates of hospitalization,…”
Get full text

Blinatumomab with Tyrosine Kinase Inhibitor for Ph-Positive B-Acute Lymphoblastic Leukemia (B-ALL): Multicenter Retrospective Review by Aleid, Manar, Alrajhi, Abdullah, Alwadi, Mohammmad, Alsugair, Ali, Alshehri, Hassan, Tailor, Imran K, Hanbali, Amr, Alfraih, Feras Abdulaziz, Alhayli, Saud, Alahmari, Ali, Albabtain, Abdulwahab, Alotaibi, Ahmad S., Alnoamani, Mohammed S, Alshehry, Nawal F, Motabi, Ibraheem H, Alzahrani, Hazza A, Marei, Mohammed A, Saad, Ayman, Aljurf, Mahmoud, Elfakih, Riad, Alhumaid, Muhned, Alfayez, Mansour

“…Background: Ph-positive B-ALL has long been considered an adverse cytogenetic abnormality in ALL, and it is generally recommended to proceed with a stem cell…”
Get full text

JAK2 GGCC (46/1) Haplotype in Unprovoked Venous Thrombotic Events by Al-Ammari, Maged, Peer Zada, Abdul Ali, Motabi, Ibraheem H., Albtoosh, Belal M., Altaf, Syed Y., Tailor, Imran K., Alnoamani, Mohammed S., Zaidi, Syed Ziauddin A, Alfayez, Mansour, Alshehry, Nawal F, Marei, Mohammed A.

“…Background: JAK2 GGCC 46/1 haplotype can be represented by four main SNPs (rs3780367, rs10974944, rs12343867, and rs1159782) which replace one cytosine and…”
Get full text

Efficacy of Brentuximab Vedotin and Bendamustine Combination in Relapsed/Refractory Hodgkin Lymphoma: Experience from a Tertiary Care Hospital by Alrajhi, Abdullah M, Aljalali, Razan A., Alghazi, Lara H., Asiri, Ibrahim, Alnakhli, Adel, Alnajjar, Fouad H., Alshehry, Nawal F, Motabi, Ibraheem H., Alnoamani, Mohammed S., Marei, Mohammed A., Alfayez, Mansour, Tailor, Imran K.

“…Background: Hodgkin lymphoma (HL) is an uncommon B-cell malignant neoplasm, with high curable rate for patients with localized disease or advanced.However, up…”
Get full text

Safety and Efficacy of Azacitidine with Venetoclax for Newly Diagnosed Intensive Chemotherapy Ineligible, and Relapsed or Refractory Acute Myeloid Leukemia in Arab Population: A Single-Center, Retrospective Study by Alwadi, Mohammmad, Howaidi, Jude, Alrajhi, Abdullah M, Alnakhli, Adel, Marei, Mohammed A., Tailor, Imran K., Alnajjar, Fouad H., Altaf, Syed Y., Alnoamani, Mohammed S., Alzahrani, Kamal, Alshehri, Hassan, Motabi, Ibraheem H., Zaidi, Syed Ziauddin A, Alshehry, Nawal F, Alfayez, Mansour

“…Background: Venetoclax combined with hypomethylating agents is a new standard of care for newly diagnosed patients with acute myeloid leukemia (AML) 75 years…”
Get full text

Blinatumomab With Tyrosine Kinase Inhibitor for Ph-Positive B-Acute Lymphoblastic Leukemia (B-ALL): Multicenter Retrospective Review by Aleid, Manar, Alrajhi, Abdullah, Alwadi, Mohammad, Alsugair, Ali, Alshehri, Hassan, Tailor, Imran K., Hanbali, Amr, Abdulaziz Alfraih, Feras, Alhayli, Saud, Alahmari, Ali, Albabtain, Abdulwahab, Alotaibi, Ahmad S., Alnoamani, Mohammed S., Alshehry, Nawal F., Motabi, Ibraheem H., Alzahrani, Hazza A., Marei, Mohammed A., Saad, Ayman, Aljurf, Mahmoud, El Fakih, Riad, Alhumaid, Muhned, Alfayez, Mansour

Get full text

ALL-676 Blinatumomab With Tyrosine Kinase Inhibitor for Ph-Positive B-Acute Lymphoblastic Leukemia (B-ALL): Multicenter Retrospective Review by Aleid, Manar, Alrajhi, Abdullah, Alwadi, Mohammad, Alsugair, Ali, Alshehri, Hassan, Tailor, Imran K., Hanbali, Amr, Alfraih, Feras Abdulaziz, Alhayli, Saud, Alahmari, Ali, Albabtain, Abdulwahab, Alotaibi, Ahmad S., Alnoamani, Mohammed S., Alshehry, Nawal F., Motabi, Ibraheem H., Alzahrani, Hazza A., Marei, Mohammed A., Saad, Ayman, Aljurf, Mahmoud, Fakih, Riad El, Alhumaid, Muhned, Alfayez, Mansour

“…Ph-positive B-ALL is considered an adverse cytogenetic abnormality in ALL, generally recommending stem cell transplantation (SCT) in first remission…”
Get full text

A National Collaborative Multicenter Phase II Study for Potential Safety Efficacy of Convalescent Plasma to Treat Severe COVID-19 Patients by Al Hashmi, Hani, Alawami, Deia, Zaidi, Syed Ziauddin A, Alshehry, Nawal F, Alzahrani, Hazza A., Zaidi, Abdul Rehman Z, Al Sagheir, Ahmed, Khojah, Osamah, Alaskar, Ahmed, AlMozain, Noura, Al-Ansari, Rehab, Alfaraj, Mona, ElGohary, Ghada, Dayel, Afra, Bahrani, Ahmed, Abdulhamid, Arwa Nabhan, Alhumaidan, Hind, Albalawi, Mohammed, AlFraedhi, Alia, Al-Otaibi, Jawaher, Abdallah, Rania

“…▪ Introduction Coronavirus disease (COVID-19) pandemic has started to affect Saudi Arabia in the beginning of March 2020 and is expected to cause significant…”
Get full text

Outcome of Myeloma Patients with COVID-19 on Active Lenalidomide-Based Therapy: Does Lenalidomide Protect From Severe COVID-19? by Tailor, Imran K, Alshehry, Nawal F, Zaidi, Syed Z, Marei, Mohammed A, Motabi, Ibraheem H, Alfayez, Mansour, Altaf, Syed Y

Get more information